Quantifying acute myocardial injury using ratiometric fluorometry

IEEE Transactions on Biomedical Engineering

Volumn 56, Issue 5, 2009, Pages 1556-1563

  Ranji, Mahsa ^a   Matsubara, Muneaki ^b   Leshnower, Bradley G ^c   Hinmon, Robin H ^d   Jaggard, Dwight L ^b   Chance, Britton ^e   Gorman, Robert C ^b   Gorman, Joseph H ^b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fluorometery; Mitochondrial disruption; Mitochondrial redox state; Myocardial infarction; Myocardial reperfusion injury

Indexed keywords

FLUOROMETERY; MITOCHONDRIAL DISRUPTION; MITOCHONDRIAL REDOX STATE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY;

AMIDES; ANIMALS; CELL DEATH; FLUORESCENCE; RISK MANAGEMENT;

FLUOROMETERS;

CYCLOSPORIN A; FLAVOPROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; EXPERIMENTAL MODEL; FLUORESCENCE ANALYSIS; FLUOROMETRY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; NONHUMAN; REPERFUSION INJURY;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FLAVOPROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NAD; OXIDATION-REDUCTION; RABBITS; SPECTROMETRY, FLUORESCENCE;

EID: 67649362461     PISSN: 00189294     EISSN: None     Source Type: Journal    
DOI: 10.1109/TBME.2008.2006029     Document Type: Article

References (22)

1. M. Gheorghiade and R. O. Bonow, "Chronic heart failure in the United States: A manifestation of coronary artery disease," Circulation, vol. 97, no. 3, pp. 282-289, Jan. 1998.
2. J. Narula, M. S. Dawson, B. K. Singh, A. Amanullah, E. R. Acio, F. A. Chaudhry, R. B. Arani, and A. E. Iskandrian, "Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy," J. Amer. Coll. Cardiol., vol. 36, no. 6, pp. 1913-1918, Nov. 2000.
3. A. Yamaguchi, T. Ito, H. Adachi, S. Murata, H. Kamio, M. Okada, and J. Tsuboi, "Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy," Ann. Thorac. Surg., vol. 65, no. 2, pp. 434-438, Feb. 1998.
4. A. S. Blom, R. Mukherjee, J. J. Pilla, A. S. Lowry, W. M. Yarbrough, J. T. Mingoia, J. W. Hendrick, R. E. Stroud, J. E. McLean, J. Affuso, R. C. Gorman, J. H. Gorman, III, M. A. Acker, and F. G. Spinale, "Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction," Circulation, vol. 112, no. 9, pp. 1274-1283, Aug. 2005.
5. J. J. Pilla, A. S. Blom, J. H. Gorman, III, D. J. Brockman, J. Affuso, L. M. Parish, H. Sakamoto, B. M. Jackson, M. A. Acker, and R. C. Gorman, "Early postinfarction ventricular restraint improves borderzone wall thickening dynamics during remodeling," Ann. Thorac. Surg., vol. 80, no. 6, pp. 2257-2262, Dec. 2005.
6. Y. Enomoto, J. H. Gorman, III, S. L. Moainie, B. M. Jackson, L. M. Parish, T. Plappert, A. Zeeshan, andM. G. St. John-Sutton, R. C. Gorman, "Early ventricular restraint after myocardial infarction: Extent of the wrap determines the outcome of remodeling," Ann. Thorac. Surg., vol. 79, no. 3, pp. 881-887, Mar. 2005.
7. R. G. McKay, M. A. Pfeffer, R. C. Pasternak, J. E. Markis, P. C. Come, S. Nakao, J. D. Alderman, J. J. Ferguson, R. D. Safian, andW. Grossman, "Left ventricular remodeling after myocardial infarction: A corollary to infarct expansion," Circulation, vol. 74, no. 4, pp. 693-702, Oct. 1986.
8. J. A. Erlebacher, J. L. Weiss, L. W. Eaton, C. Kallman, M. L. Weisfeldt, and B. H. Bulkly, "Late effects of acute infarct dilatation on heart size: A two dimensional echocardiographic study," Amer. J. Cardiol., vol. 49, no. 5, pp. 1120-1126, Apr. 1982.
9. R. A. Gottlieb, K. O. Burleson, R. A. Kloner, B. M. Babior, and R. L. Engler, "Reperfusion injury induces apoptosis in rabbit cardiomyocytes," J. Clin. Invest, vol. 94, no. 4, pp. 1621-1628, Oct. 1994.
10. H. J. Bromme and J. Holtz, "Apoptosis in the heart: When and why?," Mol. Cell. Biochem., vol. 261-275, pp. 163-164, Oct.-Nov. 1996.
11. H. L. Wyatt, S. Meerbaum, M. K. Heng, J. Rit, P. Gueret, and E. Corday, "Experimental evaluation of the extent of myocardial dyssynergy and infarct size by two-dimensional echocardiography," Circulation, vol. 63, no. 3, pp. 607-614, Mar. 1981.
12. N. G. Pandian, S. Koyanagi, D. J. Skorton, S. M. Collins, C. L. Easthm, R. A. Kieso, M. L. Marcus, and R. E. Kerber, "Relations between 2-dimensional echocardiographic wall thickening abnormalities, myocardial infarct size and coronary risk area in normal and hypertrophied myocardium in dogs," Amer. J. Cardiol., vol. 52, no. 10, pp. 1318-1325, Dec. 1983.
13. B. Chance and H. Baltscheffsky, "Respiratory enzymes in oxidative phosphorylation. VII. Binding of intramitochondrial reduced pyridine nucleotide," J. Biol. Chem., vol. 233, no. 3, pp. 736-739, Sep. 1958.
14. B. Chance and B. Schoener, "High and low energy states of cytochromes. II. In submitochondrial particles," J. Biol. Chem., vol. 241, no. 20, pp. 4577-4587, Oct. 1966.
15. M. Ranji, S. Kanemoto, M. Matsubara, M. A. Grosso, J. H. Gorman III, R. C. Gorman, D. L. Jaggard, and B. Chance, "Fluorescence spectroscopy and imaging of myocardial apoptosis," J. Biomed. Opt., vol. 11, no. 6, pp. 064036-1-064036-4, Nov.-Dec. 2006.
16. B. G. Leshnower, H. Sakamoto, A. Zeeshan, L. M. Parish, R. Hinmon, T. Plappert, J. H. Gorman III., and R. C. Gorman, "Role of acetaminophen in acute myocardial infarction," Amer. J. Physiol. Heart Circ. Physiol., vol. 81, no. 4, pp. 2424-2431, Jun. 2006.
17. L. Argaud, O. Gateau-Roesch, D. Munteam, L. Chalabreysse, J. Loufouat, D. Robert, and M. Ovize, "Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury," J. Mol. Cell. Cardiol, vol. 38, no. 2, pp. 367-374, Feb. 2005.
18. G. Kroemer, B. Dallaporta, and M. Resche-Rignon, "The mitochondrial death/life regulator in apoptosis and necrosis," Annu. Rev. Physiol., vol. 60, pp. 619-642, 1998.
19. M. R. Duchen, O. McGuiness, L. A. Brown, and M. Crompton, "On the involvement of a cyclosporin a sensitive mitochondrial pore in myocardial reperfusion injury," Cardiovasc. Res., vol. 27, no. 10, pp. 1790-1794, Oct. 1993.
20. M. Zoratti and I. Szabo, "The mitochondrial permeability transition," Bichim. Biophys. Acta, vol. 1241, no. 2, pp. 139-176, Jul. 1995.
21. J. Narula, N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and B. A. Khaw, "Apoptosis in myocytes in end-stage heart failure," N. Engl. J. Med., vol. 335, no. 16, pp. 1182-1189, Oct. 1996.
22. J. Narula, E. R. Acio, N. Narula, L. E. Samuels, B. Fyfe, D. Wood, J. M. Fitzpatrick, P. N. Raghunath, J. E. Tomaszewski, C. Kelly, N. Steinmetz, A. Green, J. F. Tait, J. Leppo, F. G. Blankenberg,D. Jain, and H.W. Strauss, "Annexin-V imaging for noninvasive detection of cardiac allograft rejection," Nat. Med., vol. 7, no. 12, pp. 1347-1352, Dec. 2001.